Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection

Wang, XH; Hu, ZL; Fu, YZ; Hou, JY; Li, WX; Zhang, YJ; Xu, L; Zhou, QF; Chen, MS; Zhou, ZG

Zhou, ZG (通讯作者)，Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China.;Zhou, ZG (通讯作者)，Sun Yat Sen Univ Canc Ctr, Dept Liver Surg, Guangzhou 510060, Guangdong, Peoples R China.;Zhou, QF (通讯作者)，Guangzhou Med Univ, Affiliated Hosp 2, Dept Minimally Invas Intervent Radiol, Guangzhou 510260, Peoples R China.;Zhou, QF (通讯作者)，Guangzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Guangzhou 510260, Peoples R China.

JOURNAL OF GASTROENTEROLOGY, 2022; 57 (3): 185

Abstract

Background Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are recommended as first-line choices regarding the treatment of chronic hepatits B......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索